AKT1 and breast cancer: Dephosphorylation of Akt and increased expression of PTEN by statin treatment is also reported to suppress PI3K/Akt/mTOR pathway in ER-positive (MCF-7, T47D) as well as ER-negative (MDA-MB-231) breast cancer cells (Wang et al., 2016).